A regulatory overview about rare diseases.

  • Jordi Llinares
  • Published 2010 in Advances in experimental medicine and biology


Rare diseases attract very little interest for drug development. To create more favourable conditions, incentives for development (scientific advice, research grants) and marketing of medicines (market exclusivity, regulatory fee reductions) are offered by several orphan legislations. These incentives have proven to be a valuable stimulus for research and… (More)
DOI: 10.1007/978-90-481-9485-8_12


  • Presentations referencing similar topics